Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $777.54 | 21 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Veloxis Pharmaceuticals, Inc. | $268.22 | 7 | $0 (2019) |
| Allergan Inc. | $133.46 | 1 | $0 (2018) |
| ABIOMED | $93.84 | 1 | $0 (2021) |
| ACELL, INC. | $84.61 | 1 | $0 (2017) |
| Bayer HealthCare Pharmaceuticals Inc. | $51.62 | 3 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $39.58 | 2 | $0 (2021) |
| GENZYME CORPORATION | $39.58 | 2 | $0 (2018) |
| Vyera Pharmaceuticals, LLC | $19.65 | 1 | $0 (2019) |
| Genentech, Inc. | $18.46 | 1 | $0 (2019) |
| Novo Nordisk Inc | $16.19 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $14.63 | 1 | Bayer HealthCare Pharmaceuticals Inc. ($14.63) |
| 2021 | $175.38 | 6 | ABIOMED ($93.84) |
| 2019 | $102.30 | 5 | Veloxis Pharmaceuticals, Inc. ($40.64) |
| 2018 | $318.97 | 5 | Veloxis Pharmaceuticals, Inc. ($169.73) |
| 2017 | $166.26 | 4 | ACELL, INC. ($84.61) |
All Payment Transactions
21 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/26/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: Cardio-renal | ||||||
| 12/16/2021 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $93.84 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/15/2021 | Novo Nordisk Inc | RYBELSUS (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.19 | General |
| Category: Diabetes | ||||||
| 09/29/2021 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $21.82 | General |
| Category: Cardio-renal | ||||||
| 08/26/2021 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.17 | General |
| Category: Cardio-renal | ||||||
| 08/04/2021 | Medtronic, Inc. | Chameleon (Device) | Food and Beverage | In-kind items and services | $12.33 | General |
| Category: Percutaneous Transluminal Angioplasty (PTA) Balloons | ||||||
| 07/26/2021 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/08/2019 | Genentech, Inc. | Actemra (Biological) | Food and Beverage | In-kind items and services | $18.46 | General |
| Category: Immunology | ||||||
| 07/11/2019 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $23.55 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/14/2019 | Veloxis Pharmaceuticals, Inc. | Envarsus (Drug), Envarsus | Food and Beverage | In-kind items and services | $29.28 | General |
| Category: Immunosuppressant | ||||||
| 05/30/2019 | Vyera Pharmaceuticals, LLC | Daraprim 30 Tablet in 1 Bottle (Drug) | Food and Beverage | In-kind items and services | $19.65 | General |
| Category: Toxoplasmosis | ||||||
| 03/07/2019 | Veloxis Pharmaceuticals, Inc. | Envarsus (Drug), Envarsus | Food and Beverage | In-kind items and services | $11.36 | General |
| Category: Immunosuppressant | ||||||
| 06/03/2018 | Veloxis Pharmaceuticals, Inc. | Envarsus XR (SP) (Drug), Envarsus XR, Envarsus XR | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Immunosuppressant | ||||||
| 05/17/2018 | Veloxis Pharmaceuticals, Inc. | Envarsus XR (SP) (Drug), Envarsus XR, Envarsus XR | Food and Beverage | In-kind items and services | $24.07 | General |
| Category: Immunosuppressant | ||||||
| 03/29/2018 | GENZYME CORPORATION | THYMOGLOBULIN (Drug) | Food and Beverage | In-kind items and services | $15.78 | General |
| Category: ONCOLOGY | ||||||
| 03/06/2018 | Allergan Inc. | STRATTICE (Device) | Food and Beverage | In-kind items and services | $133.46 | General |
| Category: TRAUMA EMERGENCY, INJURY, SURGERY | ||||||
| 02/15/2018 | Veloxis Pharmaceuticals, Inc. | Envarsus XR (SP) (Drug), Envarsus XR, Envarsus XR | Food and Beverage | In-kind items and services | $20.67 | General |
| Category: Immunosuppressant | ||||||
| 09/21/2017 | Veloxis Pharmaceuticals, Inc. | Envarsus XR (Drug), Envarsus XR, Envarsus XR | Food and Beverage | In-kind items and services | $19.57 | General |
| Category: Immunosuppressant | ||||||
| 08/21/2017 | GENZYME CORPORATION | THYMOGLOBULIN (Drug) | Food and Beverage | In-kind items and services | $23.80 | General |
| Category: ONCOLOGY | ||||||
| 06/21/2017 | ACELL, INC. | — | Food and Beverage | Cash or cash equivalent | $84.61 | General |
| 02/03/2017 | Veloxis Pharmaceuticals, Inc. | Envarsus XR (Drug), Envarsus XR, Envarsus XR | Food and Beverage | In-kind items and services | $38.28 | General |
| Category: Immunosuppressant | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 1 | 23 | 23 | $3,399 | $1,267 |
| 2020 | 3 | 68 | 68 | $38,891 | $14,629 |
All Medicare Procedures & Services
4 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99202 | New patient outpatient visit, total time 15-29 minutes | Office | 2021 | 23 | 23 | $3,399 | $1,267 | 37.3% |
| 36830 | Connection of tube graft to vein and artery for dialysis | Facility | 2020 | 17 | 17 | $23,953 | $9,392 | 39.2% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 31 | 31 | $10,478 | $3,800 | 36.3% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 20 | 20 | $4,460 | $1,438 | 32.2% |
About Dr. John Ham, MD
Dr. John Ham, MD is a Vascular Surgery healthcare provider based in Las Vegas, Nevada. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1104834639.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Ham, MD has received a total of $777.54 in payments from pharmaceutical and medical device companies, with $14.63 received in 2022. These payments were reported across 21 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($777.54).
As a Medicare-enrolled provider, Ham has provided services to 91 Medicare beneficiaries, totaling 91 services with total Medicare billing of $15,896. Data is available for 2 years (2020–2021), covering 4 distinct procedure/service records.
Practice Information
- Specialty Vascular Surgery
- Other Specialties Vascular Surgery
- Location Las Vegas, NV
- Active Since 08/03/2006
- Last Updated 03/23/2021
- Taxonomy Code 2086S0129X
- Entity Type Individual
- NPI Number 1104834639
Products in Payments
- Envarsus XR (SP) (Drug) $169.73
- STRATTICE (Device) $133.46
- Impella (Device) $93.84
- Envarsus XR (Drug) $57.85
- Kerendia (Drug) $51.62
- Envarsus (Drug) $40.64
- LOKELMA (Drug) $39.58
- THYMOGLOBULIN (Drug) $39.58
- Daraprim 30 Tablet in 1 Bottle (Drug) $19.65
- Actemra (Biological) $18.46
- RYBELSUS (Drug) $16.19
- Chameleon (Device) $12.33
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Vascular Surgery Doctors in Las Vegas
Hazem Afifi, M.d, M.D
Vascular Surgery — Payments: $42,085
Earl Cottrell, Md, MD
Vascular Surgery — Payments: $40,638
Bruce Hirschfeld, Md, MD
Vascular Surgery — Payments: $29,138
Frank Jordan, Md, MD
Vascular Surgery — Payments: $27,872
Alvancin Louis, Md, MD
Vascular Surgery — Payments: $12,694
Amir Ghaffarian, Md, MD
Vascular Surgery — Payments: $7,355